ANXA6 Contributes to Radioresistance by Promoting Autophagy via Inhibiting the PI3K/AKT/mTOR Signaling Pathway in Nasopharyngeal Carcinoma
- PMID: 32373608
- PMCID: PMC7176914
- DOI: 10.3389/fcell.2020.00232
ANXA6 Contributes to Radioresistance by Promoting Autophagy via Inhibiting the PI3K/AKT/mTOR Signaling Pathway in Nasopharyngeal Carcinoma
Abstract
Radiotherapy is a conventional and effective treatment method for nasopharyngeal carcinoma (NPC), although it can fail, mainly because radioresistance results in residual or recurrent tumors. However, the mechanisms and predictive markers of NPC radioresistance are still obscure. In this study, we identified Annexin A6 (ANXA6) as a candidate radioresistance marker by using Tandem Mass Tag quantitative proteomic analysis of NPC cells and gene chip analysis of NPC clinical samples with different radiosensitivities. It was observed that a high expression level of ANXA6 was positively correlated with radioresistance of NPC and that inhibition of ANXA6 by siRNA increased the radiosensitivity. The incidence of autophagy was enhanced in the established radioresistant NPC cells in comparison with their parent cells, and silencing autophagy with LC3 siRNA (siLC3) sensitized NPC cells to irradiation. Furthermore, ANXA6 siRNA (siANXA6) suppressed cellular autophagy by activating the PI3K/AKT/mTOR pathway, ultimately leading to radiosensitization. The combination of siANXA6 and CAL101 (an inhibitor of PI3K, p-AKT, and mTOR, concurrently) significantly reversed the above siANAX6-reduced autophagy. Suppression of PI3K/AKT/mTOR by CAL101 also increased the expression of ANXA6 in a negative feedback process. In conclusion, this study revealed for the first time that ANXA6 could promote autophagy by inhibiting the PI3K/AKT/mTOR pathway and that it thus contributes to radioresistance of NPC. The significance of this is that ANXA6 could be applied as a new predictive biomarker of NPC prognosis after radiotherapy.
Keywords: ANXA6; NPC; PI3K/AKT/mTOR; autophagy; radioresistance.
Copyright © 2020 Chen, Zheng, Zhu, Yao, Wang, Song, Hu, Liu, Bai, Pan, Zhang, Guan and Shao.
Figures





Similar articles
-
lncRNA CASC19 Contributes to Radioresistance of Nasopharyngeal Carcinoma by Promoting Autophagy via AMPK-mTOR Pathway.Int J Mol Sci. 2021 Jan 30;22(3):1407. doi: 10.3390/ijms22031407. Int J Mol Sci. 2021. PMID: 33573349 Free PMC article.
-
Silencing c-Jun inhibits autophagy and abrogates radioresistance in nasopharyngeal carcinoma by activating the PI3K/AKT/mTOR pathway.Ann Transl Med. 2021 Jul;9(13):1085. doi: 10.21037/atm-21-2563. Ann Transl Med. 2021. PMID: 34422997 Free PMC article.
-
RNA binding motif protein 3 (RBM3) drives radioresistance in nasopharyngeal carcinoma by reducing apoptosis via the PI3K/AKT/Bcl-2 signaling pathway.Am J Transl Res. 2018 Dec 15;10(12):4130-4140. eCollection 2018. Am J Transl Res. 2018. PMID: 30662656 Free PMC article.
-
Pre-treatment with angiotensin-(1-7) inhibits tumor growth via autophagy by downregulating PI3K/Akt/mTOR signaling in human nasopharyngeal carcinoma xenografts.J Mol Med (Berl). 2018 Dec;96(12):1407-1418. doi: 10.1007/s00109-018-1704-z. Epub 2018 Oct 29. J Mol Med (Berl). 2018. PMID: 30374682 Free PMC article.
-
Targeting PI3K/AKT/mTOR Signaling Pathway as a Radiosensitization in Head and Neck Squamous Cell Carcinomas.Int J Mol Sci. 2022 Dec 12;23(24):15749. doi: 10.3390/ijms232415749. Int J Mol Sci. 2022. PMID: 36555391 Free PMC article. Review.
Cited by
-
Silencing of NACC1 inhibits the proliferation, migration and invasion of nasopharyngeal carcinoma cells via regulating the AKT/mTOR signaling pathway.Oncol Lett. 2021 Dec;22(6):828. doi: 10.3892/ol.2021.13088. Epub 2021 Oct 12. Oncol Lett. 2021. PMID: 34691255 Free PMC article.
-
Establishment of prognostic model of bladder cancer based on apoptosis-related genes, in which P4HB promotes BLCA progression.BMC Urol. 2023 Oct 16;23(1):167. doi: 10.1186/s12894-023-01331-5. BMC Urol. 2023. PMID: 37845668 Free PMC article.
-
Breast Cancer Stem Cell-Derived ANXA6-Containing Exosomes Sustain Paclitaxel Resistance and Cancer Aggressiveness in Breast Cancer.Front Cell Dev Biol. 2021 Oct 5;9:718721. doi: 10.3389/fcell.2021.718721. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34676207 Free PMC article.
-
Activation of PI3K/AKT/mTOR Pathway Causes Drug Resistance in Breast Cancer.Front Pharmacol. 2021 Mar 15;12:628690. doi: 10.3389/fphar.2021.628690. eCollection 2021. Front Pharmacol. 2021. PMID: 33790792 Free PMC article. Review.
-
NEDD8 promotes radioresistance via triggering autophagy formation and serves as a novel prognostic marker in oral squamous cell carcinoma.Cancer Cell Int. 2023 Mar 8;23(1):41. doi: 10.1186/s12935-023-02883-0. Cancer Cell Int. 2023. PMID: 36890567 Free PMC article.
References
-
- Chamcheu J. C., Roy T., Uddin M. B., Banang-Mbeumi S., Chamcheu R. N., Walker A. L., et al. (2019). Role and therapeutic targeting of the pi3k/akt/mtor signaling pathway in skin cancer: a review of current status and future trends on natural and synthetic agents therapy. Cells Basel 8:803. 10.3390/cells8080803 - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous